SIRT1 and prostate carcinoma: Interestingly, our results differed from previous reports which indicated that SIRT1 serves as a positive regulator of epithelial-mesenchymal transition, the metastatic growth of prostate cancer cells [62], and is associated with malignancy in chronic myelogenous leukemia [63].